$NGTF
NightFood Holdings, Inc. Stock $ngtf

$ngtf Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023099837 Filed on December 29, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$8.470K	$29.51K
YoY Change	-89.41%	-75.92%
Cost Of Revenue	$57.58K	$53.69K
YoY Change	-53.98%	-57.53%
Gross Profit	-$49.11K	-$24.18K
YoY Change	8.77%	523.2%
Gross Profit Margin	-579.81%	-81.94%
Selling, General & Admin	$160.0K	$404.8K
YoY Change	26.65%	44.62%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$433.7K	$404.8K
YoY Change	-32.09%	44.62%
Operating Profit	-$425.2K	-$429.0K
YoY Change	-23.88%	51.16%
Interest Expense	-$795.6K	-$400.1K
YoY Change	410.22%	60.78%
% of Operating Profit
Other Income/Expense, Net	-$1.008M	-$103.6K
YoY Change	85.08%	-279.49%
Pretax Income	-$1.433M	-$974.2K
YoY Change	19.31%	105.14%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$1.433M	-$990.7K
YoY Change	19.31%	108.6%
Net Earnings / Revenue	-16919.03%	-3357.1%
Basic Earnings Per Share	-$0.01
Diluted Earnings Per Share	-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	124.8M shares	120.6M shares
Diluted Shares Outstanding	124.8M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.420K	$44.19K
YoY Change	-97.54%	-84.27%
Cash & Equivalents	$5.424K	$44.19K
Short-Term Investments
Other Short-Term Assets	$38.42K	$92.73K
YoY Change	-64.01%	-32.71%
Inventory	$160.8K	$276.2K
Prepaid Expenses	$9.020K
Receivables	$30.28K	$33.40K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$234.9K	$446.5K
YoY Change	-73.63%	-47.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles		$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$234.9K	$446.5K
Total Long-Term Assets	$0.00	$0.00
Total Assets	$234.9K	$446.5K
YoY Change	-73.63%	-47.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$615.7K	$563.7K
YoY Change	41.72%	140.76%
Accrued Expenses	$82.58K
YoY Change	817.56%
Deferred Revenue
YoY Change
Short-Term Debt	$1.745M	$1.492M
YoY Change	95.03%	333.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.576M	$2.198M
YoY Change	91.92%	280.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.576M	$2.198M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$2.576M	$2.198M
YoY Change	91.92%	280.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.44M	-$34.99M
YoY Change	22.92%	24.51%
Common Stock	$126.9K	$123.6K
YoY Change	32.26%	34.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.341M	-$1.752M
YoY Change
Total Liabilities & Shareholders Equity	$234.9K	$446.5K
YoY Change	-73.63%	-47.09%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.433M	-$990.7K
YoY Change	19.31%	108.6%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$89.76K	-$217.5K
YoY Change	-78.35%	-36.23%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$51.00K	235.1K
YoY Change	-85.6%	135.11%
NET CHANGE
Cash From Operating Activities	-$89.76K	-217.5K
Cash From Investing Activities		0.000
Cash From Financing Activities	$51.00K	235.1K
Net Change In Cash	-$38.76K	17.52K
YoY Change	-35.89%	-107.26%
FREE CASH FLOW
Cash From Operating Activities	-$89.76K	-$217.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	000-55406
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	NIGHTFOOD HOLDINGS, INC.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3885019
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 White Plains Road
CY2023Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Tarrytown
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10591
CY2023Q3	dei	City Area Code CityAreaCode	888
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	888-6444
CY2023Q3	dei	Security12b Title Security12bTitle	N/A
CY2023Q3	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127221301	shares
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5424	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44187	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30281	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33396	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	160756	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	276202	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	38416	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	234877	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	446511	usd
CY2023Q3	us-gaap	Assets Assets	234877	usd
CY2023Q2	us-gaap	Assets Assets	446511	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	698260	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	604516	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1745100	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1491719	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2576061	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2198111	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126921301	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126921301	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123587968	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123587968	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	126921	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	123588	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33973831	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33112935	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36441939	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34988126	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2341184	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1751600	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	234877	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	446511	usd
CY2023Q3	us-gaap	Revenues Revenues	8470	usd
CY2022Q3	us-gaap	Revenues Revenues	79970	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	57580	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	125121	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	-7131	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	37166	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	160011	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	126341	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	223200	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	349949	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	433660	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	638577	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-425190	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-558607	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	212259	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	544545	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	43693	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	22946	usd
CY2023Q3	us-gaap	Financing Interest Expense FinancingInterestExpense	751900	usd
CY2022Q3	us-gaap	Financing Interest Expense FinancingInterestExpense	132983	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	57971	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1007852	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-642503	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1201110	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	20771	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	345462	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1453813	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1546572	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124783621	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92713941	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1751600	usd
CY2023Q3	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	50000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	84230	usd
CY2023Q3	ngtf	Stock Issued During Period Value Warrants Issued As Financing Cost Associated With Convertible Notes StockIssuedDuringPeriodValueWarrantsIssuedAsFinancingCostAssociatedWithConvertibleNotes	9878	usd
CY2023Q3	ngtf	Warrants Issued As Financing Cost WarrantsIssuedAsFinancingCost	699350	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1433042	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2341184	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	265576	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	20010	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	290070	usd
CY2022Q3	ngtf	Warrants Issued And Warrants Dilutive Adjustment As Financing Cost WarrantsIssuedAndWarrantsDilutiveAdjustmentAsFinancingCost	65783	usd
CY2022Q3	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustment	108126	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1201110	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-451545	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1433042	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1201110	usd
CY2023Q3	ngtf	Stock Issued For Financing Cost StockIssuedForFinancingCost	50000	usd
CY2022Q3	ngtf	Stock Issued For Financing Cost StockIssuedForFinancingCost	20010	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	212259	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	544545	usd
CY2023Q3	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	84230	usd
CY2022Q3	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	108126	usd
CY2023Q3	ngtf	Warrants And Returnable Warrants Issued For Financing1 WarrantsAndReturnableWarrantsIssuedForFinancing1	699350	usd
CY2022Q3	ngtf	Warrants And Returnable Warrants Issued For Financing1 WarrantsAndReturnableWarrantsIssuedForFinancing1	65783	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	113196	usd
CY2023Q3	ngtf	Write Down Of Other Current Assets WriteDownOfOtherCurrentAssets	46130	usd
CY2022Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4041	usd
CY2022Q3	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	57971	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3115	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36723	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2250	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	101657	usd
CY2023Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-8180	usd
CY2022Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-31052	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	93744	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	200294	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	30825	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	9000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-89763	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-414610	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	51000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	644000	usd
CY2022Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	289855	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	354145	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-38763	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-60465	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44187	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280877	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5424	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220412	usd
CY2022Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	28180	usd
CY2023Q3	ngtf	Debt And Warrants Discount Accounted On Convertible Notes DebtAndWarrantsDiscountAccountedOnConvertibleNotes	9878	usd
CY2022Q3	ngtf	Debt And Warrants Discount Accounted On Convertible Notes DebtAndWarrantsDiscountAccountedOnConvertibleNotes	290070	usd
CY2022Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	4050	usd
CY2022Q3	ngtf	Deemed Dividend Associated With Warrants Dilutive Adjustment DeemedDividendAssociatedWithWarrantsDilutiveAdjustment	345462	usd
CY2023Q3	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span><b>1. Description of Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Nightfood Holdings, Inc. (“we”, “us”, “the Company” or “Nightfood”) is a Nevada corporation incorporated on October 16, 2013 to acquire all of the issued and outstanding shares of Nightfood, Inc., a New York corporation from its sole shareholder, Sean Folkson. All of our operations are conducted through our subsidiary Nightfood, Inc. We are also the sole shareholder of MJ Munchies, Inc., which owns certain intellectual property but does not have any operations as of the period covered by these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Our corporate address is 520 White Plains Road – Suite 500, Tarrytown, New York 10591 and our telephone number is 888-888-6444. We maintain a web site at www.nightfood.com, along with many additional web properties. Any information that may appear on our web site should not be deemed to be a part of this report.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company’s fiscal year end is June 30.</span></p>
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Use of Estimates</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used in the determination of depreciation and amortization, the valuation for non-cash issuances of common stock, and the website, income taxes and contingencies, valuing convertible preferred stock for a “beneficial conversion feature” (“BCF”) and warrants among others.</span></td> </tr></table>
CY2023Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	113196	usd
CY2023Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	7131	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	37166	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	124241	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	163644	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	28193	usd
CY2023Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Concentration of Credit Risk</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions. At various times during the year, the Company may exceed the federally insured limits. To mitigate this risk, the Company places its cash deposits only with high credit quality institutions. Management believes the risk of loss is minimal. At September 30, 2023 and June 30, 2023, the Company did not have any uninsured cash deposits.</span></td> </tr></table>
CY2023Q3	ngtf	Description Of Beneficial Conversion Feature DescriptionOfBeneficialConversionFeature	(i) 5,000 shares of the Registrant’s common stock (one share for each $0.20 of liquidation preference) (the “Conversion Shares”) and (ii) 5,000 common stock purchase warrants, expiring April 16, 2026 (the “Warrants”). The Warrants carried an initial exercise price of $0.30 per share. Subsequent financing events and debt extinguishment resulted in adjustments to the exercise price of all warrants created from conversion of B Preferred from $0.30 per share to approximately $0.1324 per share through September 30, 2023.
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	4400000
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1100000	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	63734	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	8322	usd
CY2023	ngtf	Customer Rate Percentage customerRatePercentage	0.56	pure
CY2023Q3	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span><b>Reclassification</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may make certain reclassifications to prior period amounts to conform with the current year’s presentation. Such reclassifications would not have a material effect on its consolidated statement of financial position, results of operations or cash flows.</span></td> </tr></table>
CY2023Q3	us-gaap	Profit Loss ProfitLoss	1433042	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-89763	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36441939	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	48824	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	160756	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	276202	usd
CY2023Q3	us-gaap	Inventory Adjustments InventoryAdjustments	113196	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9020	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	29396	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	92726	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	38416	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	82578	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	40779	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	615682	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	563737	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	698260	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	604516	usd
CY2022Q2	ngtf	Convertible Price Per Share ConvertiblePricePerShare	0.2
CY2023Q3	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	1000000	usd
CY2023Q3	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	100000	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	15192	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	5434783	shares
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1086957	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q3	ngtf	Forbearance Agreement Description ForbearanceAgreementDescription	The Company shall pay to each Purchaser in cash the sum of $482,250.00 for the full and complete satisfaction of the Notes, which includes all due and owing principal, interest and penalties notwithstanding anything to the contrary in the Notes, as follows: (i) $250,000.00 on or before February 7, 2023; (ii) $50,000.00 on or before February 28, 2023; (iii) $50,000.00 on or before March 31, 2023; (iv) $50,000.00 on or before April 30, 2023; and (v) $82,250.00 on or before May 31, 2023.
CY2023Q3	ngtf	Schedule Of Exchange Of Returnable Warrants For Shares Of Common Stock ScheduleOfExchangeOfReturnableWarrantsForSharesOfCommonStock	<span>Below is a reconciliation of the extinguishment of debt relative to the exchange of Returnable Warrants for shares of common stock by the holders:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">3,800,000 shares of common stock issued and exchanged for 10,869,566 returnable warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">342,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loss on conversion price change in December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,051,801</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock settled debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,988,402</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Financing charges due to returnable warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">987,060</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Principal increased due to penalty</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,703</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loss on extinguishment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">392,459</td><td style="text-align: left"> </td></tr> </table>
CY2022Q3	ngtf	Shares Of Common Stock Issued Returnable Warrants SharesOfCommonStockIssuedReturnableWarrants	3800000	shares
CY2022Q3	ngtf	Shares Of Common Stock Exchanged For Returnable Warrants SharesOfCommonStockExchangedForReturnableWarrants	10869566	shares
CY2022Q3	ngtf	Common Stock Returnable Warrants CommonStockReturnableWarrants	342000	usd
CY2022Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1051801	shares
CY2022Q3	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	1988402	usd
CY2022Q3	ngtf	Financing Charges Due To Returnable Warrants Issued FinancingChargesDueToReturnableWarrantsIssued	987060	usd
CY2022Q3	ngtf	Under Forbearance Agreement UnderForbearanceAgreement	58703	usd
CY2022Q3	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	392459	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	539570	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	21546	usd
CY2022Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	561116	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023Q3	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	604800	usd
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	49995	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	16088	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	33907	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1500000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	7000000	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.3
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q1	ngtf	Warrants To Purchase Shares WarrantsToPurchaseShares	57000	shares
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.1
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	169941	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q3	us-gaap	Payments For Fees PaymentsForFees	6840	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	170000	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	30000	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	55250	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	9750	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	600000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	ngtf	Common Stock As Commitment Shares CommonStockAsCommitmentShares	1477272	shares
CY2023Q3	ngtf	Warrants To Purchase Shares WarrantsToPurchaseShares	23021	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	650000	shares
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	82578	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	40779	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03333
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	ngtf	Outstanding Share In Percentage OutstandingShareInPercentage	0.50	pure
CY2023Q3	ngtf	Offering Description OfferingDescription	the Company launched a Tier 2 offering pursuant to Regulation A (also known as “Regulation A+”) with the intent to raise capital through an equity crowdfunding campaign. The Company is offering (this “Offering”) up to 5,000,000 units, each unit consisting of 4 shares of common stock and 4 common stock purchase warrants (“Unit”), being offered at a price range to be determined after qualification pursuant to Rule 253(b).
CY2022Q3	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	4050000	shares
CY2023Q2	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	0	shares
CY2022Q2	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	335	shares
CY2023	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	0	usd
CY2022	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	335000	usd
CY2023Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	5000	shares
CY2023Q3	ngtf	Warrants warrants	5000	shares
CY2023Q3	ngtf	Transaction Amount TransactionAmount	4431387	usd
CY2023Q3	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	1136946	usd
CY2022	ngtf	Warrants Issued WarrantsIssued	4000000	shares
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.25
CY2022Q2	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	1.4339	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0125	pure
CY2023	us-gaap	Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions	12870000	shares
CY2023	ngtf	Aggregate Of Shares AggregateOfShares	6549128	shares
CY2023	ngtf	Stock Purchase Warrants StockPurchaseWarrants	4928260	shares
CY2023Q2	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	1.2175	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0406	pure
CY2023Q3	ngtf	Purchase Warrants Description PurchaseWarrantsDescription	During the fiscal year ended June 30, 2023 the Company issued 1,871,800 warrants to various subscribers under its Tier 2 offering pursuant to Regulation A (also known as “Regulation A+”) pursuant to which the Company is offering up to 5,000,000 units at a price of $0.50 per unit, each unit consisting of 4 shares of Common Stock and 4 Common Stock purchase warrants (“Unit”) for exercise at a strike price per Share equal to 125% of the price per share of Common Stock, or $0.15625 per share with a term of 2 years.
CY2023	ngtf	Aggregate Common Stock Shares AggregateCommonStockShares	5750000	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	276066	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	377560	usd
CY2023Q3	ngtf	Warrants Issued WarrantsIssued	650000	shares
CY2023Q3	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	1.2486	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0438	pure
CY2023Q3	ngtf	Returnable Warrants Issued ReturnableWarrantsIssued	7000000	shares
CY2023Q3	ngtf	Additional Financing Costs In Cumulative Amount AdditionalFinancingCostsInCumulativeAmount	699350	usd
CY2023Q3	ngtf	Outstanding Share Purchase Warrants OutstandingSharePurchaseWarrants	24098865	shares
CY2023Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.1324
CY2023Q3	ngtf	Warrant Description WarrantDescription	Certain warrants in the below table include dilution protection for the warrant holders, which could cause the exercise price to be adjusted either higher or lower as a result of various financing events and stock transactions. The result of the warrant exercise price downward adjustment on modification date is treated as a deemed dividend and fully amortized on the transaction date. In addition to the reduction in exercise price, with certain warrants there is a corresponding increase to the number of warrants to the holder on a prorated basis. Under certain conditions, such as the successful retirement of a convertible note through repayment, it is possible for the exercise price of these warrants to increase and for the number of warrants outstanding to decrease.
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3299000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4215000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	500000	shares
CY2022Q1	us-gaap	Revenues Revenues	1000000	usd
CY2023Q3	ngtf	Warrants Description WarrantsDescription	an additional 3,000,000 warrants with a $0.50 strike price when the Company records its first quarter with revenues over $3,000,000, and an additional 3,000,000 warrants with a $1 strike price when the Company records its first quarter with revenues over $5,000,000. Mr. Folkson will also be awarded warrants with a strike price of $0.50 should the Company exceed $500,000 in non-traditional retail channel revenue during the term of the agreement, and should the Company enter into a product development or distribution partnership with a multi-national food & beverage conglomerate during the term of the Agreement.
CY2023Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12	pure
CY2023Q3	ngtf	Consulting Fees ConsultingFees	44625	usd
CY2023Q2	ngtf	Consulting Fees ConsultingFees	27000	usd
CY2023Q3	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.033
CY2023Q3	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1433042	usd
CY2023Q3	ngtf	Deemed Dividends Associated With Warrants Related Dilutive Adjustments DeemedDividendsAssociatedWithWarrantsRelatedDilutiveAdjustments		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022Q3	ngtf	Deemed Dividends Associated With Warrants Related Dilutive Adjustments DeemedDividendsAssociatedWithWarrantsRelatedDilutiveAdjustments		usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q3	ngtf	Write Down Of Other Current Assets WriteDownOfOtherCurrentAssets		usd
CY2023Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023Q3	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2023Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2023Q3	ngtf	Deemed Dividend Associated With Warrants Dilutive Adjustment DeemedDividendAssociatedWithWarrantsDilutiveAdjustment		usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2023Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2023Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001593001

Files In Submission

Name	View Source	Status
ngtf-20230930_cal.xml	Edgar Link	unprocessable
ngtf-20230930_def.xml	Edgar Link	unprocessable
ngtf-20230930_pre.xml	Edgar Link	unprocessable
ngtf-20230930_lab.xml	Edgar Link	unprocessable
0001213900-23-099837-index-headers.html	Edgar Link	pending
0001213900-23-099837-index.html	Edgar Link	pending
0001213900-23-099837.txt	Edgar Link	pending
0001213900-23-099837-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_nightfood.htm	Edgar Link	pending
f10q0923ex32-1_nightfood.htm	Edgar Link	pending
f10q0923ex4-3_nightfood.htm	Edgar Link	pending
f10q0923ex4-6_nightfood.htm	Edgar Link	pending
f10q0923_nightfood.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ngtf-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_nightfood_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NGTF
NightFood Holdings, Inc. Stock $ngtf

2023 Q3 Form 10-Q Financial Statement

#000121390023099837 Filed on December 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF NightFood Holdings, Inc. Stock $ngtf

2023 Q3 Form 10-Q Financial Statement

#000121390023099837 Filed on December 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF
NightFood Holdings, Inc. Stock $ngtf